CDR-MODIFIED ANTI-SIGLEC-15 ANTIBODY

• 收藏
• 分享

专利权人:

DAIICHI SANKYO COMPANY; LIMITED

发明人:

HIRUMA, YOSHIHARU,KIMURA, TAKAKO,SHIMIZU, HIRONARI

申请号：

PH12014502187

公开号：

PH12014502187A1

申请日:

2014.09.29

申请国别(地区):

PH

年份:

2014

代理人:

摘要：

To provide an abnormal-bone-metabolism treatment and/or a prophylactic pharmaceutical composition targeting a protein coded for by a gene that is strongly expressed in osteoclasts. The provision, etc., of a pharmaceutical composition containing an antibody that specifically recognizes human SIGLEC15 and exhibits the effect of inhibiting the formation of osteoclasts.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/